Pinealon (Glu-Asp-Arg)
Overview
Pinealon is a synthetic tripeptide (Glu-Asp-Arg, EDR) studied as a pineal cytoprotective peptide. Where Epitalon is framed around telomerase and melatonin rhythm, Pinealon’s literature centres on protecting pinealocytes from oxidative stress, supporting circadian regulation and improving stress resistance. It is a research compound.
Chemical Profile
| Property | Value |
|---|---|
| CAS number | 292422-98-9 |
| Class | Synthetic pineal tripeptide |
| Amino-acid sequence | H-Glu-Asp-Arg-OH |
| One-letter code | EDR (3 aa) |
| Molecular formula | C₁₅H₂₆N₆O₈ |
| Molecular weight | ≈ 418.4 g/mol |
| Purity (HPLC) | ≥ 98% |
| Appearance | White to off-white lyophilized powder |
- Class
- Synthetic pineal tripeptide
- Sequence
- Glu-Asp-Arg (EDR)
- Research status
- Preclinical and clinical (Eastern Europe)
- Study routes
- Subcutaneous (primary), intranasal
- Half-life
- ≈ 20–40 min
- Key feature
- Pinealocyte protection; stress resistance
Mechanism of Action
Pinealon is a short peptide designed to reproduce the cytoprotective activity of endogenous pineal factors. Its studied mechanism centres on the pinealocyte: reducing reactive-oxygen-species production, supporting mitochondrial function and antioxidant enzymes, and limiting apoptosis — which is linked in the literature to circadian support and improved stress resistance.
| Component | Detail |
|---|---|
| Primary target | Pinealocyte mitochondrial function |
| Oxidative stress | Reduced ROS; support for SOD and glutathione peroxidase |
| Anti-apoptotic | Studied for caspase inhibition |
| AANAT | Support for the melatonin-synthesis enzyme |
| HPA axis | Reported cortisol normalisation |
| Stress resistance | A prominent theme in Pinealon research |
Pharmacology
| Parameter | Value |
|---|---|
| Half-life (t½) | ≈ 20–40 min |
| Bioavailability (SC) | Moderate (short peptide) |
| Metabolism | Rapid proteolytic degradation |
| Route of administration | Subcutaneous, intranasal |
| Elimination | Renal (amino acids / fragments) |
Research Evidence
Representative studies and their focus are named below; specific numerical outcomes are not restated here as claims.
| Study type | Research focus | Reference |
|---|---|---|
| Pinealocyte / neuronal cultures | Oxidative-stress protection | Pinealon preclinical literature |
| Rodent stress / hypoxia models | Stress resistance and neuroprotection | Pinealon preclinical literature |
| Clinical aging observation | Circadian and cognitive markers | Khavinson VK, et al. (Eastern Europe) |
Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):
| Reported direction / finding | Context | Reference |
|---|---|---|
| Pinealocyte protection from oxidative stress | cell models | Pinealon literature |
| Stress-resistance and neuroprotective effects | rodent stress models | Pinealon literature |
For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.
Dosing & Reconstitution Reference
Reconstitution and handling parameters for laboratory research. Not dosing guidance for human use.
| Parameter | Reference value |
|---|---|
| Research dose range (literature) | ≈ 5–10 mg per cycle-day (SC), in study protocols |
| Reconstitution solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Storage (lyophilized) | −20°C, protected from light |
| Storage (reconstituted) | 2–8°C, up to ~1 week |
| Do not use | If the solution is cloudy or contains particulates |
Safety Profile
Published research observations, provided for reference only. This material is not for human or veterinary use.
| Category | Published observations |
|---|---|
| Tolerability | Well tolerated in reported studies |
| Local | Mild injection-site reactions possible |
| Cytotoxicity | No cytotoxicity reported |
| Status | For research use only; not for human or veterinary application |
Physicochemical Properties
| Property | Value |
|---|---|
| Physical state | White to off-white lyophilized powder |
| Solubility (water) | Freely soluble |
| logP | ≈ −3.8 (very hydrophilic) |
| Isoelectric point (pI) | ≈ 6.5 (near neutral) |
| pH (reconstituted) | 5.0–6.5 |
| Stability (lyophilized) | ≥ 24 months at −20°C |
Synthesis & Manufacturing
Pinealon is a 3-residue peptide made by Fmoc solid-phase synthesis — a short, straightforward synthesis, purified by preparative HPLC to research grade.
| Step | Detail |
|---|---|
| Strategy | Fmoc solid-phase peptide synthesis |
| Resin | Wang resin (C-terminal acid) |
| Coupling | HBTU / HOBt with DIPEA |
| Cleavage | TFA / TIPS / H₂O (95 : 2.5 : 2.5) |
| Purification | Preparative RP-HPLC (C18, TFA/ACN gradient) |
- Notes: coupling efficiency and complete Fmoc removal are monitored each cycle; hindered or repeated residues (e.g. Arg-Arg) may need double coupling.
- Preparative RP-HPLC removes deletion and truncation impurities to reach research-grade purity; salt exchange (lyophilization from dilute HCl) removes residual TFA/acetate.
- Critical quality attributes: correct molecular weight and low deletion-peptide content. A very short tripeptide; dissolves rapidly.
Analytical Methods
| Method | Parameter | Typical result |
|---|---|---|
| RP-HPLC (C18, UV 214 nm) | Purity | ≥ 98% |
| HPLC retention | C18, reversed-phase TFA/ACN gradient | Single main peak |
| ESI-MS (positive mode) | Identity / mass | [M+H]⁺ ≈ 419 Da |
| MALDI-TOF | Mass confirmation | [M+H]⁺ ≈ 419 Da |
| Amino-acid analysis | Composition | Consistent with the stated sequence |
| LC-MS (extracted ion) | Deletion-peptide impurities | Within specification |
| Karl Fischer | Water content | < 6% |
| LAL assay | Endotoxin | Within specification |
| Ion chromatography | Residual TFA | < 500 ppm |
Representative RP-HPLC purity method:
- Column: C18, 5 µm, 250 × 4.6 mm
- Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
- Gradient: reversed-phase TFA/ACN gradient · Flow rate: 1.0 mL/min · Detection: UV 214 nm
- Confirmatory LC-MS: ESI positive mode ([M+H]⁺ ≈ 419 Da). A very short tripeptide; dissolves rapidly.
Stability Data
Representative stability behaviour under common storage, handling and formulation conditions.
| Condition | Duration | Result |
|---|---|---|
| Lyophilized, −20°C, dark | ≥ 24 months | No significant degradation (purity > 97%) |
| Lyophilized, 2–8°C, dark | ≥ 12 months | Minimal degradation (purity > 95%) |
| Lyophilized, 25°C (accelerated) | 3 months | < 5% degradation |
| Reconstituted, 2–8°C, dark | 7–14 days | Minor degradation |
| Reconstituted, 25°C | 24–48 h | Use promptly |
| Light exposure (ICH Q1B) | 1.2 M lux·h | Generally light-stable |
| Freeze–thaw (−20°C ⇄ 25°C) | 3 cycles | Acceptable — aliquot to avoid repeats |
- Keep lyophilized powder cold, dry and light-protected; keep any solution refrigerated and protected from light.
- Minimise freeze-thaw cycles; aliquot material used across many sessions.
- Key factor: A very short tripeptide; dissolves rapidly.
Selected References
- Khavinson VK, et al. Short peptides and pineal / pinealocyte regulation (Pinealon literature).
- Reviews of pineal regulatory peptides and cytoprotection.
Quality & Supply
- HPLC ≥ 98% purity with a Certificate of Analysis per batch
- Identity confirmed by LC-MS
- Research samples through to bulk, with worldwide delivery
- Custom quantities and packaging on request
Need Pinealon — sample or bulk?
HPLC-verified, COA per batch. Tell us the quantity you need.
